FDA pilots new inspection programme
This article was originally published in Clinica
FDA officials have introduced a pilot programme to make plant inspections more compatible with the agency's 1997 quality systems regulation (QSR) which updates the agency's good manufacturing practices requirements by embracing the quality systems approach to manufacturing.
You may also be interested in...
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.
Israel-based Binah.ai hopes to earn regulatory approval for a video-based monitoring app that can detect vital signs in minutes. See what Binah.ai's co-founder and CEO, David Maman, said about the technology here.